19.04.2023 - Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Polivy (polatuzumab vedotin-piiq) in combination with Rituxan (rituximab), cyclophosphamide, .
If you’re just starting your career in Clinical Research, trying to understand all of the acronyms used in various roles can be confusing. To help, we’ve put together this list of 100 acronyms used in Clinical Research for you to know .
The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.
Fluvoxamine, which is currently used to treat mental health conditions, was chosen for study as a potential treatment for COVID-19 due to its anti-inflammatory properties.
Washington, October 28
An inexpensive repurposed drug, fluvoxamine, may reduce hospital admissions in high-risk COVID-19 patients by up to 30 per cent, according to a study published in The Lancet Gl